AI Article Synopsis
- Limited knowledge exists about Talaromyces marneffei infection in children, prompting a retrospective study involving 11 HIV-negative pediatric patients.
- The study revealed a mortality rate of 36.36%, with many children having underlying diseases and significant immune system issues.
- Voriconazole was the primary treatment, showing positive results in most cases, while also highlighting the importance of recognizing this infection as a sign of severe immunodeficiencies in children.
Article Abstract
Knowledge about the clinical and laboratory characteristics and prognosis of Talaromyces marneffei infection in children is limited. A retrospective study was conducted on pediatric patients with disseminated T. marneffei infection in a clinical setting. Extracted data included demographic information (age and sex), clinical features, laboratory findings, treatment, and prognosis. Eleven HIV-negative children were enrolled. The male/female ratio was 8:3. The median age of onset was 17.5 months (3.5-84 months). The mortality rate in these children was 36.36% (4/11). Seven children had underlying diseases. All of the children had multiple immunoglobulin abnormalities and immune cell decline. Ten children received voriconazole treatment, and most of the children (7/10) had a complete response to therapy at primary and long-term follow-up assessment; only three children died of talaromycosis. One patient recovered from talaromycosis but died of leukemia. The child who received itraconazole treatment also showed clinical improvement. No adverse events associated with antifungal therapies were recorded during and after the treatment. Talaromycosis is an indicator disease for undiagnosed severe immunodeficiencies in children. Awareness of mycoses in children by pediatricians may prompt diagnosis and timely treatment. Voriconazole is an effective, well-tolerated therapeutic option for disseminated T. marneffei infection in non-HIV-infected children.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11046-019-00373-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Talaromyces marneffei central nervous system infection unveiled by the novel Mp1p antigen detection assay in AIDS patient.
BMC Infect Dis
December 2024
Central Laboratory, Chongqing Public Health Medical Centre, Chongqing, China.
Background: In acquired immunodeficiency syndrome patients, Talaromyces marneffei infections are mostly disseminated and may involve the skin, mucosa, respiratory system, digestive system, lymphatic system, and as some reports indicate, the nervous system. Mp1p, a cell wall-specific polysaccharide in Talaromyces marneffei, is used for laboratory diagnosis of Talaromyces marneffei in blood and urine samples. However, Cerebrospinal fluid Mp1p diagnosis of Talaromyces marneffei central nervous system infection has not been reported.
View Article and Find Full Text PDFThe Diagnosis of Talaromyces marneffei Central Nervous System Infection in an HIV-Negative Child by Cytological Assay of a Cerebrospinal Fluid Smear.
Mycopathologia
December 2024
Clinical Laboratory, Department of Clinical Laboratory, The People's Hospital of Longhua Shenzhen, Shenzhen, 518109, People's Republic of China.
Prevalence of bone destruction in patients with TALAROMYCES MARNEFFEI infection: A systematic review and meta-analysis.
Int J Infect Dis
December 2024
College of Public Hygiene of Guangxi Medical University, Nanning, Guangxi, China.
Objectives: This systematic review and meta-analysis aimed to evaluate the prevalence of bone destruction in patients with Talaromyces marneffei infection, examine distribution patterns of bone lesions, and assess differences between HIV-positive and HIV-negative patients.
Methods: Following PRISMA guidelines, 15 studies involving 839 patients were analyzed. Random-effects meta-analysis was performed to estimate prevalence and odds ratios.
[ infection complicated by talaromycosis in a patient with positive anti-interferon-γ autoantibodies: a case report].
Zhonghua Jie He He Hu Xi Za Zhi
December 2024
Department of Respiratory and Critical Care Medicine, Fuzhou Provincial Hospital Affiliated to Fuzhou University, Fuzhou350001, China.
Article Synopsis
- - High levels of antibodies to interferon-gamma (IFN-γ) are linked to infections from intracellular pathogens, especially non-tuberculous mycobacteria (NTM) and tuberculosis (MTB).
- - The case study discusses a non-immunosuppressed patient who had both MTB infection and complications from NTM, which led to a severe condition called secondary hemophagocytic syndrome.
- - The report emphasizes the importance of recognizing this uncommon combination of infections to prevent misdiagnosis or unnecessary treatments for patients.
Acute respiratory failure caused by Penicillium Marneffei infection after Kidney Transplantation:A case report.
Respir Med Case Rep
November 2024
Department of General Intensive Care Unit, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Article Synopsis
- Penicillium Marneffei (PM) infections can show vague symptoms, but severe respiratory failure is rare; this case discusses a patient who faced this issue after a kidney transplant.
- The report covers the patient's diagnosis of PM infection and respiratory failure, along with the various treatments used, such as drug therapy and specialized ventilation strategies.
- Key treatment aspects included balancing bleeding and clotting risks, initiating early nutrition, and progressing to pulmonary rehab exercises, making the case a useful reference for critical care in similar situations.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!